RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1016%2F0197-2456%2895%2900134-4

https://w3id.org/ripe/ripe-kg/work/10.1016%2F0197-2456%2895%2900134-4

Subject	Predicate	Object
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`prism:doi`	10.1016/0197-2456(95)00134-4
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`dcterms:title`	Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	node1
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	`http://purl.org/spar/fabio/Work`
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	`rdfs:Resource`
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	`owl:Thing`
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	`prov:Entity`
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`rdf:type`	`ripe:Work`Work
`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?	`owl:sameAs`	`https://semopenalex.org/work/W1986215651`
`ripekg:work/10.1080%2F08989621.2022.2082290`A randomized trial alerting authors, with or without coauthors or editors, that research they cited in systematic reviews and guidelines has been retracted	`http://purl.org/spar/cito/cites`	`ripekg:work/10.1016%2F0197-2456%2895%2900134-4`Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?